[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
December 11, 2018

Failure to Disclose Conflict of Interest in Article Published in JAMA on Detection of Cancer-Related Genes

Author Affiliations
  • 1Vall d´Hebron Institute of Oncology (VHIO), Cellex Center, Barcelona, Spain
JAMA. 2018;320(22):2380. doi:10.1001/jama.2018.16961

To the Editor I write to take full responsibility for failing to report appropriate conflict of interest disclosures in articles published in JAMA and the JAMA Network journals between 2015 and 2018, including “Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing,” published in the September 5, 2017, issue of JAMA.1 In that article, I had reported nothing to disclose. In the interest of full disclosure, I now report the following financial interests and activities that I had been involved in from 2013 to the present, regardless of potential relevance: